NO992999L - Farmasöytisk blanding for oral administrering - Google Patents

Farmasöytisk blanding for oral administrering

Info

Publication number
NO992999L
NO992999L NO992999A NO992999A NO992999L NO 992999 L NO992999 L NO 992999L NO 992999 A NO992999 A NO 992999A NO 992999 A NO992999 A NO 992999A NO 992999 L NO992999 L NO 992999L
Authority
NO
Norway
Prior art keywords
oral administration
pharmaceutical composition
basic drug
oral
cyclodextrin
Prior art date
Application number
NO992999A
Other languages
English (en)
Other versions
NO992999D0 (no
Inventor
Masayuki Takahashi
Hiromi Morita
Hiroshi Kikuchi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO992999D0 publication Critical patent/NO992999D0/no
Publication of NO992999L publication Critical patent/NO992999L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Foreliggende oppfinnelse angår et farmasøytisk preparat for oral admini- strering, omfattende et basisk medikament, en lipofil substans og/eller et cyklodekstrin. Preparatet oppviser forbedret peroral absorpsjon av et basisk medikament som vanskelig absorberes ved oral administrering.
NO992999A 1996-12-19 1999-06-18 Farmasöytisk blanding for oral administrering NO992999L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33963896 1996-12-19
PCT/JP1997/004650 WO1998026803A1 (fr) 1996-12-19 1997-12-17 Composition pharmaceutique pour administration par voie orale

Publications (2)

Publication Number Publication Date
NO992999D0 NO992999D0 (no) 1999-06-18
NO992999L true NO992999L (no) 1999-08-18

Family

ID=18329398

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992999A NO992999L (no) 1996-12-19 1999-06-18 Farmasöytisk blanding for oral administrering

Country Status (5)

Country Link
EP (1) EP0953359A4 (no)
AU (1) AU719076B2 (no)
CA (1) CA2275475A1 (no)
NO (1) NO992999L (no)
WO (1) WO1998026803A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1043020A1 (en) * 1997-12-25 2000-10-11 Daiichi Pharmaceutical Co., Ltd. Medicinal composition for percutaneous administration
WO1999037643A1 (en) * 1998-01-26 1999-07-29 Yamanouchi Pharmaceutical Co., Ltd. Novel benzene-fused heterocyclic derivatives or salts thereof
FR2793687B1 (fr) * 1999-04-26 2001-08-24 Sanofi Sa Nouvelle composition injectable d'un anticoagulant
US20030149061A1 (en) * 2000-04-04 2003-08-07 Yoshitaka Nishihara Oily compositions containing highly fat-soluble drugs
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ES2314227T7 (es) 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
JP4732696B2 (ja) 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56128714A (en) * 1980-03-07 1981-10-08 Intaretsukusu Research Corp Oral absorption-improved beta-lactam antibiotic oral dosage
KR880012221A (ko) * 1987-04-13 1988-11-26 사노 가즈오 에스테르 또는 아미드를 활성성분으로 함유하는 약제 조성물
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JPH07196483A (ja) * 1993-11-25 1995-08-01 Taisho Pharmaceut Co Ltd 経口吸収性を改善した製剤組成物
EP0712844A4 (en) * 1994-06-06 1996-11-06 Green Cross Corp NEW CONDENSED CARBONIC ACID OR YOUR SALT AND YOUR MEDICAL USE
JPH092977A (ja) * 1995-06-21 1997-01-07 Dai Ichi Seiyaku Co Ltd 経口投与用医薬組成物

Also Published As

Publication number Publication date
EP0953359A4 (en) 2001-12-19
NO992999D0 (no) 1999-06-18
EP0953359A1 (en) 1999-11-03
WO1998026803A1 (fr) 1998-06-25
AU7735798A (en) 1998-07-15
AU719076B2 (en) 2000-05-04
CA2275475A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
BR9810495A (pt) Composição farmacêutica
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE185562T1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
ES2163511T3 (es) Preparacion farmaceutica conteniendo glucagon.
EE04799B1 (et) Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
BRPI9917007B8 (pt) azabicicloalcanos como moduladores de ccr5, composição farmacêutica contendo os mesmos, bem como seu uso
EE03692B1 (et) 19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
BR0014312B1 (pt) composição farmacêutica contendo uma combinação farmacêutica compreendendo loteprednol e azelastina, medicamento e seu processo de produção, e uso da referida combinação.
BR9606674B1 (pt) novo derivado de composto de antraciclina e preparação farmacêutica contendo o mesmo.
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
EE03395B1 (et) Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised
NO307048B1 (no) N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)- etyl]-2,2-difenylacetamidhydroklorid, legemiddel som inneholder forbindelsen, anvendelse av legemidlet til fremstilling av legemiddelpreparater, farmasøytiske preparater som inneholder l
AR021845A1 (es) Derivados de 1,3-diaril-2-piridin-2-il-3-(piridin-2-ilamino)-propanol sustituidos, composiciones farmaceuticas y medicamentos que las comprenden, procedimientos para su preparacion, medicamentos que contienen estos compuestos, y su utilizacion para la preparcion de medicamentos
NO962006L (no) Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem
DE69610085D1 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
EE04347B1 (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, neid sisaldav ravim ja farmatseutiline kompositsioon
BR0009281B1 (pt) derivados de morfolina, processo de preparação dos mesmos, composições farmacêuticas que os contêm, uso dos referidos derivados e medicamento.
ES2188909T3 (es) Nuevos derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes o enfermedades relacionados con el estrogeno. os
FI950818L (fi) Uudet substituoidut sulfoniamidit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI972129A0 (fi) 6-metoksi-1H-bentsotriatsoli-5-karboksamidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkekoostumuksia
FR2701709B1 (fr) Forme purifiée de streptograminés, sa préparation et les compositions pharmaceutiques qui la contiennent.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application